SCHEMBL18199848

SCHEMBL18199848

COc1ccccc1-n1c(C)cc2cccc(C)c2c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MAPT P10636 3/20 0.50
KDM4E B2RXH2 2/20 0.50
HTT P42858 2/20 0.50
HPGD P15428 2/20 0.50
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.44
PIK3CG P48736 1/20 0.42
LMNA P02545 5/20 0.42
TP53 P04637 2/20 0.42
TSHR P16473 1/20 0.41
MGLL Q99685 1/20 0.41
METAP2 P50579 1/20 0.41
GAA P10253 1/20 0.41
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16596190 0.87 ALDH1A1 (0.48) ALDH1A1MAPTKDM4EHTTHPGD
SCHEMBL16596827 0.87 ALDH1A1 (0.48) ALDH1A1MAPTKDM4EHTTHPGD
SCHEMBL16596818 0.86 PIK3CD (0.49) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL16596974 0.77 ALDH1A1 (0.53) ALDH1A1MAPTKDM4EHTTHPGD
SCHEMBL16596154 0.77 ALDH1A1 (0.43) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL1129587 0.75 PIK3CG (0.51) ALDH1A1MAPTKDM4EHTTHPGD
SCHEMBL18056732 0.75 MEN1 (0.40) ALDH1A1MAPTKDM4EHTTHPGD
SCHEMBL16596153 0.75 PIK3CD (0.44) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL16596953 0.74 L3MBTL1 (0.72) ALDH1A1MAPTKDM4EHTTHPGD
SCHEMBL13781780 0.72 PIK3CD (0.45) ALDH1A1MAPTKDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512114-B2 Substituted aminopyrimidine compounds and methods of use CALITOR SCIENCES, LLC (US) 2016-12-06 US disclosed
US-20160318914-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE CALITOR SCIENCES, LLC (US) 2016-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318914-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE PIK3CA, PIK3CD, MYD88 ALDH1A1 2302/4885MAPT 4477/4885KDM4E 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.